UK Markets closed
  • NIKKEI 225

    27,968.99
    -58.85 (-0.21%)
     
  • HANG SENG

    18,597.23
    +392.55 (+2.16%)
     
  • CRUDE OIL

    80.47
    +2.27 (+2.90%)
     
  • GOLD FUTURES

    1,771.00
    +7.30 (+0.41%)
     
  • DOW

    34,053.59
    +201.06 (+0.59%)
     
  • BTC-GBP

    14,081.65
    +352.82 (+2.57%)
     
  • CMC Crypto 200

    401.67
    +0.98 (+0.24%)
     
  • Nasdaq

    11,207.53
    +223.75 (+2.04%)
     
  • ^FTAS

    4,139.65
    +27.35 (+0.67%)
     

OTCMKTS : $OCEL

EQS-News: Organicell Regenerative Medicine, Inc.
OTCMKTS : $OCEL 📋 Organicell Activates COPD Trial at Mayo Clinic!
16.11.2022 / 19:20 CET/CEST
The issuer is solely responsible for the content of this announcement.

Contact Details

Organicell Investor Relations

IR@organicell.com

Company Website

https://organicell.com/


News Source: News Direct


16.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:

English

Company:

Organicell Regenerative Medicine, Inc.

United States

ISIN:

US68621D1072

EQS News ID:

1489793


 

End of News

EQS News Service

show this
show this